Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Guardant Health, Inc.GH · Entity 3238 | Director | September 15, 2026 | September 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Guardant Health, Inc.
Report date September 15, 2026 · Filed September 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,449 |
Ending reported balance
After 2026-09-16 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-15 · Exercise / conversion · Acquired 249 · Balance 11,565 Row 2 · 2026-09-16 · Sale · Disposed 116 · Balance 11,449 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 1,500 |
Reported balance
After 2026-09-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-15 · Exercise / conversion · Disposed 249 · Balance 1,500 F1: The restricted stock unit award granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award vested on March 15, 2024 and the remaining 75% vests monthly for the three-year period thereafter. F2: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock unit award granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award vested on March 15, 2024 and the remaining 75% vests monthly for the three-year period thereafter.
F2: Not applicable for Restricted Stock Units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2025 Filed Jun 16, 2025 23:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000177 · wk-form4_1750116347.xml · derivative · entry 4 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,247 Underlying: Common Stock · 250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The restricted stock units granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of March 15, 2023 and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 15, 2025 Filed Jun 16, 2025 23:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000177 · wk-form4_1750116347.xml · nonDerivative · entry 2 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,403 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 23:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 6,674 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000177 · wk-form4_1750116347.xml · derivative · entry 3 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,674 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units vest in full on the one-year anniversary of the grant date, June 12, 2024 or the date of the next year annual stockholders meeting, whichever is earlier. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 23:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 6,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000177 · wk-form4_1750116347.xml · nonDerivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2025 Filed May 20, 2025 20:57 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 116 | $40.04 | $4,644.64 |
DisclosureSEC source: 0001576280-25-000153 · wk-form4_1747774669.xml · nonDerivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,479 Read SEC document |
| May 15, 2025 Filed May 19, 2025 23:12 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000151 · wk-form4_1747696343.xml · derivative · entry 2 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,497 Underlying: Common Stock · 250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit award granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of March 15, 2023 and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| May 15, 2025 Filed May 19, 2025 23:12 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000151 · wk-form4_1747696343.xml · nonDerivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 17, 2025 Filed Apr 18, 2025 17:35 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 116 | $44.79 | $5,195.64 |
DisclosureSEC source: 0001576280-25-000131 · wk-form4_1744997696.xml · nonDerivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,345 Read SEC document |
| April 15, 2025 Filed Apr 16, 2025 20:46 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000128 · wk-form4_1744836406.xml · derivative · entry 2 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,747 Underlying: Common Stock · 250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units granted on March 6, 2023 vest over a four-year period. 25% of the shares vested on the one-year anniversary of March 15, 2023 and the remaining 75% vests monthly during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 15, 2025 Filed Apr 16, 2025 20:46 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000128 · wk-form4_1744836406.xml · nonDerivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 21:05 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 116 | $43.70 | $5,069.20 |
DisclosureSEC source: 0001576280-25-000102 · wk-form4_1742504705.xml · nonDerivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,211 Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:33 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 249 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000100 · wk-form4_1742333619.xml · derivative · entry 2 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,997 Underlying: Common Stock · 249 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of March 15, 2023 and the remaining 75% vest monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:33 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 249 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000100 · wk-form4_1742333619.xml · nonDerivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,327 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 22:54 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 116 | $48.33 | $5,606.28 |
DisclosureSEC source: 0001576280-25-000046 · wk-form4_1740178458.xml · nonDerivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,078 Read SEC document |
| February 15, 2025 Filed Feb 18, 2025 21:58 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000042 · wk-form4_1739915920.xml · derivative · entry 2 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,246 Underlying: Common Stock · 250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit award granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of March 15, 2023, and the remaining 75% vests monthly during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| February 15, 2025 Filed Feb 18, 2025 21:58 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000042 · wk-form4_1739915920.xml · nonDerivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,194 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 17, 2025 Filed Jan 21, 2025 22:11 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 116 | $37.58 | $4,359.28 |
DisclosureSEC source: 0001576280-25-000030 · wk-form4_1737497508.xml · nonDerivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,944 Read SEC document |
| January 15, 2025 Filed Jan 16, 2025 22:07 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000028 · wk-form4_1737065262.xml · derivative · entry 2 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,496 Underlying: Common Stock · 250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit award granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of March 15, 2023, and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 15, 2025 Filed Jan 16, 2025 22:07 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000028 · wk-form4_1737065262.xml · nonDerivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2024 Filed Dec 19, 2024 23:29 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 116 | $34.85 | $4,042.60 |
DisclosureSEC source: 0001576280-24-000315 · wk-form4_1734650958.xml · nonDerivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,810 Read SEC document |
| December 15, 2024 Filed Dec 16, 2024 23:11 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000301 · wk-form4_1734390659.xml · derivative · entry 3 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,746 Underlying: Common Stock · 250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of March 15, 2023, and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| December 15, 2024 Filed Dec 16, 2024 23:11 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000301 · wk-form4_1734390659.xml · nonDerivative · entry 2 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2024 Filed Dec 16, 2024 23:11 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 2,320 | $35.00 | $81,200.00 |
DisclosureSEC source: 0001576280-24-000301 · wk-form4_1734390659.xml · nonDerivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,676 Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 00:34 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000285 · wk-form4_1731976439.xml · derivative · entry 2 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,996 Underlying: Common Stock · 250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of March 15, 2023, and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 00:34 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000285 · wk-form4_1731976439.xml · nonDerivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,996 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2024 Filed Oct 16, 2024 22:33 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000249 · wk-form4_1729118028.xml · derivative · entry 2 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,246 Underlying: Common Stock · 250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of March 15, 2023, and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 15, 2024 Filed Oct 16, 2024 22:33 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000249 · wk-form4_1729118028.xml · nonDerivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,746 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2024 Filed Sep 16, 2024 21:34 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 249 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000224 · wk-form4_1726522473.xml · derivative · entry 2 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,496 Underlying: Common Stock · 249 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of March 15, 2023, and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| September 15, 2024 Filed Sep 16, 2024 21:34 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 249 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000224 · wk-form4_1726522473.xml · nonDerivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,496 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 21:18 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000194 · wk-form4_1724102333.xml · derivative · entry 2 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,745 Underlying: Common Stock · 250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of March 15, 2023, and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 21:18 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000194 · wk-form4_1724102333.xml · nonDerivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 20:35 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000178 · wk-form4_1721162117.xml · derivative · entry 2 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,995 Underlying: Common Stock · 250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of March 15, 2023, and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 20:35 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000178 · wk-form4_1721162117.xml · nonDerivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,997 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2024 Filed Jun 17, 2024 22:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000156 · wk-form4_1718664291.xml · derivative · entry 2 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,245 Underlying: Common Stock · 250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of March 15, 2023, and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 15, 2024 Filed Jun 17, 2024 22:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000156 · wk-form4_1718664291.xml · nonDerivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 01:00 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 6,674 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000142 · wk-form4_1718326799.xml · derivative · entry 2 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,674 Underlying: Common Stock · 6,674 shares Expires not disclosed F2 · derivative.exercise_date: The restricted stock units vest in full on the one-year anniversary of the grant date, June 12, 2024 or the date of the next year annual stockholders meeting, whichever is earlier. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 01:00 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantStock Option (Right to Buy) · Derivative | 10,703 | $0.00 Strike: $31.84 | $0.00 |
DisclosureSEC source: 0001576280-24-000142 · wk-form4_1718326799.xml · derivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,703 Underlying: Common Stock · 10,703 shares Expires 2034-06-12 F1 · derivative.exercise_date: The stock option vests in full on the one-year anniversary of the grant date, June 12, 2024 or the date of the next year annual stockholders meeting, whichever is earlier. Read SEC document |
| May 15, 2024 Filed May 16, 2024 22:17 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000119 · wk-form4_1715897807.xml · derivative · entry 2 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,495 Underlying: Common Stock · 250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of March 15, 2023, and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| May 15, 2024 Filed May 16, 2024 22:17 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000119 · wk-form4_1715897807.xml · nonDerivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2024 Filed Apr 16, 2024 22:36 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 249 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000094 · wk-form4_1713307001.xml · derivative · entry 2 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,745 Underlying: Common Stock · 249 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of March 15, 2023, and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 15, 2024 Filed Apr 16, 2024 22:36 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 249 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000094 · wk-form4_1713307001.xml · nonDerivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 22:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 2,998 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000063 · wk-form4_1710800154.xml · derivative · entry 2 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,994 Underlying: Common Stock · 2,998 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of March 15, 2023, and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 22:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 2,998 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000063 · wk-form4_1710800154.xml · nonDerivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 22:09 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 18,237 | $0.00 Strike: $30.23 | $0.00 |
DisclosureSEC source: 0001576280-23-000034 · wf-form4_167822694868889.xml · derivative · entry 2 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,237 Underlying: COMMON STOCK · 18,237 shares Expires 2033-03-05 F3 · derivative.exercise_date: The stock option granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of March 15, 2023, and the remaining 75% vests monthly for the three-year period thereafter. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 22:09 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRESTRICTED STOCK UNITS · Derivative | 11,992 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000034 · wf-form4_167822694868889.xml · derivative · entry 1 Tariq Musa · CIK 0001968281 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,992 Underlying: COMMON STOCK · 11,992 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of March 15, 2023, and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.